SCHEMBL4748717

SCHEMBL4748717

CC(C)(C)c1ccccc1C(C)(C)C.Cc1ccccc1-c1ccccc1P

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.42
GABRB2 P47870 1/20 0.42
TSHR P16473 2/20 0.38
ALDH1A1 P00352 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HPGD P15428 1/20 0.35
CA2 P00918 1/20 0.34
NPC1 O15118 1/20 0.34
CASP3 P42574 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
KIF11 P52732 1/20 0.33
ACHE P22303 1/20 0.33
BRD4 O60885 1/20 0.33
HTR7 P34969 1/20 0.32
AR P10275 1/20 0.31
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10177352 0.85 TSHR (0.45) TSHRALDH1A1HPGDCA2NPC1
SCHEMBL782074 0.83 TSHR (0.43) TSHRALDH1A1HPGDCA2NPC1
Hydrochloric Acid SCHEMBL28380244 0.83 TSHR (0.43) TSHRALDH1A1TDP1HPGDCA2
SCHEMBL20034068 0.81 GABRA1 (0.50) GABRA1GABRB2TSHRALDH1A1TDP1
SCHEMBL9960735 0.77 GABRA1 (0.35) GABRA1GABRB2TSHRALDH1A1TDP1
SCHEMBL28153792 0.76 CA2 (0.38) GABRA1GABRB2TSHRALDH1A1TDP1
SCHEMBL18307741 0.74 GABRA1 (0.44) GABRA1GABRB2TSHRALDH1A1TDP1
SCHEMBL2220167 0.74 ALDH1A1 (0.50) GABRA1GABRB2TSHRALDH1A1TDP1
SCHEMBL2911757 0.73 GABRA1 (0.68) GABRA1GABRB2TSHRALDH1A1TDP1
Bromide SCHEMBL15251935 0.72 ALDH1A1 (0.48) GABRA1GABRB2TSHRALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008121861-A2 PYRAZOLE AND PYRROLE COMPOUNDS USEFUL IN TREATING IRON DISORDERS XENON PHARMACEUTICALS INC. (CA) 2008-10-09 WO disclosed